Aspira Women's Health
Biotech firm, Aspira Women's Health Inc., pioneers diagnostic tests and treatments for gynecologic issues in Texas.
Founded
2000Biotech firm, Aspira Women's Health Inc., pioneers diagnostic tests and treatments for gynecologic issues in Texas.
Aspira Women's Health Inc., a biotech firm, was founded with the mission to transform women's gynecologic health, starting with ovarian cancer. The company focuses on the discovery, development, and commercialization of innovative diagnostic tests and treatments for gynecologic issues. Aspira Women's Health aims to provide early detection solutions for ovarian cancer risk, striving to improve outcomes for women of all races and ethnicities, regardless of menopausal status. Their market focus is primarily in Texas.
Notable affiliated individuals include key researchers and medical professionals specializing in gynecology and oncology. Aspira Women's Health has garnered attention from significant investors in the biotech and healthcare sectors. Key achievements include the development of advanced diagnostic tests that have the potential to revolutionize early detection and treatment of ovarian cancer. The company's impact lies in its commitment to improving women's health outcomes through cutting-edge biotechnology.
Companies similar to Aspira Women's Health include Hera Biotech, Ovagene Oncology, Daré Bioscience and Oviva Therapeutics.
Aspira Women's Health was founded in 2000.
Aspira Women's Health's headquarters is located in Austin, TX, US.
Aspira Women's Health's most recent funding round was for $45M (USD) in February 2021.
As of Feb 4, 2021, Aspira Women's Health has disclosed funding of $146M (USD). Undisclosed round amounts are excluded.
Aspira Women's Health has 85 employees as of Feb 6, 2024.
Oviva Therapeutics
ovivatx.com
